Trial Profile
Clinical and pharmacokinetic study of PM00104 in Phase II (Zalypsis) in Patients with Advanced Urothelial Carcinoma and / or Metastatic Progress After a First Line Platinum Based Treatment. [Estudio Clínico y Farmacocinético en Fase II de PM00104 (Zalypsis) en Pacientes con Carcinoma Urotelial Avanzado y/o Metastático que Progresa Después de una Primera Línea de Tratamiento Basado en Platino.]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs PM 00104 (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Sponsors PharmaMar
- 28 Mar 2012 Status changed from recruiting to completed.
- 27 Jun 2011 New trial record